Skip to main content
Print Save

Gemtesa Disease Interactions

There is 1 disease interaction with Gemtesa (vibegron).

Moderate

Vibegron (applies to Gemtesa) urinary retention

Moderate Potential Hazard, Moderate plausibility.

Vibegron may increase the risk of urinary retention, particularly in patients with bladder outlet obstruction and in those taking muscarinic antagonist medications to treat overactive bladder (OAB). It is recommended to monitor for signs and symptoms of urinary retention and discontinue the use of vibegron if a patient develops urinary retention.

References

  1. "Product Information. Gemtesa (vibegron)." Urovant Sciences, Inc (2021):

Gemtesa drug interactions

There are 9 drug interactions with Gemtesa (vibegron).

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer